| Non-Alcoholic Fatty Liver Disease |
1 |
1 |
| Biliary Disease |
0 |
1 |
| Aminotransferase |
0 |
0.57 |
| Diet |
0 |
0.55 |
| Liver |
0 |
0.46 |
| Metabolism |
0 |
0.46 |
| Fatty Liver |
0 |
0.45 |
| Liver Disease |
0 |
0.45 |
| Lipids Management |
0 |
0.37 |
| High Density Lipoprotein (HDL) cholesterol |
0 |
0.19 |
| LDL Cholesterol |
0 |
0.19 |
| Blood |
0 |
0.18 |
| Cardiovascular Risk Management |
0 |
0.18 |
| Exercise |
0 |
0.18 |
| Lipoproteins |
0 |
0.18 |
| Triglycerides |
0 |
0.18 |
| Weight Loss |
0 |
0.18 |
| Weight Management |
0 |
0.14 |
| Hemoglobin A1c |
0 |
0.13 |
| Abdomen |
0 |
0.09 |
| Clinical Research |
0 |
0.09 |
| Grant |
0 |
0.09 |
| Hemoglobin |
0 |
0.09 |
| Insulin Resistance |
0 |
0.09 |
| Plasma |
0 |
0.09 |
| Healthcare and Medical Technology |
0 |
0.07 |
| Neuroendocrine Tumor |
0 |
0.07 |